CLEC3B/Tetranectin Antibody (805035) [Alexa Fluor® 647]

• Reactivity: Hu
• Applications: WB, B/N
• Clone: 805035
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 647

CLEC3B/Tetranectin Antibody (805035) [Alexa Fluor® 647] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human CLEC3B/Tetranectin
  Glu22-Val202
  Accession # P05452
• Specificity: Detects human CLEC3B/Tetranectin in direct ELISAs.
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Blockade of Receptor-ligand Interaction
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CLEC3B/Tetranectin Antibody (805035) [Alexa Fluor® 647]

• CLEC3B
• C-type lectin domain family 3 member B
• C-type lectin domain family 3, member B
• DKFZp686H17246
• Plasminogen kringle 4-binding protein
• TETN
• tetranectin (plasminogen binding protein)
• Tetranectin
• TNA
• TNAtetranectin (plasminogen-binding protein)
• TNtetranectin

Background

CLEC3B (C-type lectin domain family 3-member B; also Tetranectin) is a 20 kDa, secreted member of the C type lectin superfamily. It is produced by multiple cell types including monocytes, neutrophils, fibroblasts, hepatocytes and various endocrine cells. Although named Tetranectin, CLEC3B is actually a nondisulfide linked homotrimer. It binds to plasminogen, sulfated polysaccharides, and fibrin. Human CLEC3B precursor is 202 amino acids (aa) in length. It contains a signal sequence (aa 1-21), a coiled coil region that mediates trimerization (aa 26-52) and a C type lectin domain (aa 77-198). CLEC3B contains O-linked glycosylation. Mature human CLEC3B is 81% aa identical to mouse CLEC3B.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.